Table 2 Cause of death for patients diagnosed from 01 January 2019–31 January 2020 (Pre-COVID, n = 110) and those diagnosed from 01 February 2020–31 July 2021 (Post-COVID, n = 213).

From: Delayed diagnosis resulting in increased disease burden in multiple myeloma: the legacy of the COVID-19 pandemic

 

Pre-COVID

Post-COVID

Mortality: N (%)

27 (24.5)

32 (15.0)

Progressive disease: N (%)

9 (33.3)

17 (53.1)

Infection:

Sepsis

3 (11.1)

2 (6.2)

COVID-19

5 (18.5)

7 (21.9)

Cardio-respiratory failure

6 (22.2)

1 (3.1)

Cerebrovascular accident

0 (0.0)

1 (3.1)

Second primary malignancy

1 (3.7)

0 (0.0)

Upper GI bleed

0 (0.0)

1 (3.1)

Unknown

3 (11.1)

3 (0.9)

Back to article page